守护生命的“心”路——周玉杰教授

doi:10.3969/j.issn.1006-7795.2020.05.023

首都医科大学学报 ›› 2020, Vol. 41 ›› Issue (5): 844-848.doi: 10.3969/j.issn.1006-7795.2020.05.023

守护生命的“心”路——周玉杰教授

许晓晗, 程宇婧, 刘晓丽, 周玉杰

首都医科大学附属北京安贞医院北京市心肺血管疾病研究所, 北京 100029

收稿日期:2020-08-31 出版日期:2020-10-21 发布日期:2020-10-26
通讯作者: 周玉杰 E-mail:azzyj12@163.com

Guardian of the heart——Professor Zhou Yujie

Xu Xiaohan, Cheng Yujing, Liu Xiaoli, Zhou Yujie

Beijing Anzhen Hospital, Capital Medical University;Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing 100029, China

Received:2020-08-31 Online:2020-10-21 Published:2020-10-26

摘要/Abstract

摘要： 周玉杰教授从医以来，不忘初心，砥砺前行，在冠状动脉粥样硬化性心脏病（以下简称冠心病）微创介入治疗、冠心病与相关疾病领域交叉研究、冠心病创新技术及精准治疗等方面取得突破性进展，系列研究成果国际领先，入选北京学者。

关键词: 北京学者, 冠状动脉粥样硬化性心脏病, 介入治疗

Abstract: Professor Zhou Yujie has always stayed true to the mission and forged ahead since he started his medical career. He has made breakthroughs in interventional treatment of coronary heart disease, cross-research on coronary heart disease and related diseases, innovative technology and precision treatment of coronary heart disease. He was selected as one of the Beijing Scholars based on his outstanding accomplishments.

Key words: Beijing Scholars, coronary heart disease, interventional therapy

中图分类号:

R541

许晓晗, 程宇婧, 刘晓丽, 周玉杰. 守护生命的“心”路——周玉杰教授[J]. 首都医科大学学报, 2020, 41(5): 844-848.

Xu Xiaohan, Cheng Yujing, Liu Xiaoli, Zhou Yujie. Guardian of the heart——Professor Zhou Yujie[J]. Journal of Capital Medical University, 2020, 41(5): 844-848.

参考文献

[1] Yan Z X, Zhou Y J, Zhao Y X, et al. Anatomical study of forearm arteries with ultrasound for percutaneous coronary procedures[J]. Circ J, 2010, 74(4):686-692.
[2] Shen H, Zhou Y J, Liu Y Y, et al. Assessment of early radial injury after transradial coronary intervention by high-resolution ultrasound biomicroscopy:innovative technology application[J]. Chin Med J (Engl),2012, 125(19):3388-3392.
[3] Yang S W, Zhou Y J, Hu D Y, et al. Association between admission hypoglycaemia and in-hospital and 3-year mortality in older patients with acute myocardial infarction[J]. Heart, 2010, 96(18):1444-1450.
[4] Wang Z J, Zhou Y J, Liu Y Y, et al. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents[J]. Heart, 2009, 95(19):1587-1592.
[5] Du Y, Ji Q, Cai L, et al. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis[J]. Cardiovasc Diabetol, 2016, 15:90.
[6] Ji Q, Zhang J, Du Y, et al. Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4(SFRP4) levels are increased in patients with coronary artery disease[J]. Cardiovasc Diabetol,2017, 16(1):133.
[7] Zhu Y, Hu C, Du Y, et al. Time-dependent change in omentin-1 level correlated with early improvement of myocardial function in patients with first anterior ST-segment elevation myocardial infarction after primary percutaneous coronary intervention[J]. J Atheroscler Thromb, 2019, 26(10):856-867.
[8] Du Y, Yang L, Liu Y, et al. Relation between quantity and quality of peri-coronary epicardial adipose tissue and its underlying hemodynamically significant coronary stenosis[J]. BMC Cardiovasc Disord, 2020, 20(1):226.
[9] Nie B, Cheng W J, Li Y F, et al. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention[J]. Catheter Cardiovasc Interv, 2008, 72(7):958-965.
[10] Yu Y, Zhou Y, Ma Q, et al. The conical stent in coronary artery improves hemodynamics compared with the traditional cylindrical stent[J]. Int J Cardiol, 2017, 227:166-171.
[11] Ji Q, Zeng Q, Huang Y, et al. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome[J]. Mediators Inflamm, 2014, 2014:165742.
[12] Chai M, Ji Q, Zhang H, et al. The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes[J]. J Interferon Cytokine Res,2015, 35(7):530-539.

[1]	陈璐, 郭新颖, 刘建, 杜凤和, 郭彩霞. 冠状动脉粥样硬化性心脏病患者可溶性高级糖基化终末产物受体与肾功能的相关性分析[J]. 首都医科大学学报, 2022, 43(2): 167-172.
[2]	孙昊, 郑美丽, 郭宗生, 张智勇, 李晓涛. 左心室收缩功能对经皮冠状动脉介入治疗的急性下壁ST段抬高型心肌梗死患者预后的影响[J]. 首都医科大学学报, 2022, 43(2): 305-310.
[3]	夏宁, 聂秀红, 王昊, 樊晓君. 支气管哮喘合并OSA与冠心病发病率的相关性研究[J]. 首都医科大学学报, 2022, 43(1): 138-142.
[4]	刘瑾春, 郑秀花, 李宁, 张瑞霞, 张海柱. 不稳定型心绞痛患者冠状动脉侧支循环形成的预测因素研究[J]. 首都医科大学学报, 2021, 42(4): 642-646.
[5]	谷珊珊, 卢洁, 陈刚. 心肌灌注显像半定量分析对不同缺血程度老年冠状动脉粥样硬化性心脏病的诊断价值[J]. 首都医科大学学报, 2021, 42(1): 26-30.
[6]	胡宾, 周玉杰, 贾德安, 秦政, 许晓晗, 杨士伟, 周志明. 冠状动脉斑块旋磨联合药物洗脱支架术对不同年龄段老年钙化治疗效果的对比分析[J]. 首都医科大学学报, 2021, 42(1): 101-104.
[7]	李响, 蒲连美, 阮杨, 李红, 金泽宁. 汉族人群ADIPOR1 rs7539542与冠状动脉粥样硬化性心脏病和2型糖尿病的关联分析[J]. 首都医科大学学报, 2020, 41(6): 935-942.
[8]	江涛. 脑胶质瘤精准医疗——江涛教授[J]. 首都医科大学学报, 2020, 41(5): 854-859.
[9]	李扬, 董然, 芮宏亮, 刘韬帅, 郑居兵, 徐晓宇, 赵洋, 宋邦荣, 张魁. 合并慢性肾功能不全的冠状动脉粥样硬化性心脏病患者冠状动脉搭桥手术的预后及其影响因素[J]. 首都医科大学学报, 2020, 41(4): 597-602.
[10]	房达, 赵乾, 杜宁, 赵隶嬴, 马良, 崔石昌. 肝癌放射介入治疗患者辐射剂量的分析[J]. 首都医科大学学报, 2020, 41(3): 454-457.
[11]	国家卫生健康委脑卒中防治工程专家委员会, 国家卫生健康委脑卒中防治工程委员会医院管理委员会, 国家卫生健康委脑卒中防治工程专家委员会急诊专业委员会. 新型冠状病毒肺炎疫情时期脑卒中绿色通道管理专家共识[J]. 首都医科大学学报, 2020, 41(2): 293-297.
[12]	魏嘉洁, 矫杰, 周迎生. 2型糖尿病合并阻塞性睡眠呼吸暂停综合征的临床特征及其危险因素[J]. 首都医科大学学报, 2020, 41(1): 35-39.
[13]	熊筱伟, 郭彩霞, 徐晓薇, 穆利英, 胡宏宇, 陈威, 陈步星. 血浆氧化三甲胺及其前体物质浓度与冠状动脉粥样硬化性心脏病的关系[J]. 首都医科大学学报, 2020, 41(1): 99-102.
[14]	夏勇, 张建卿, 王少霞, 陈丹, 姬建民. 沙库巴曲缬沙坦联合琥珀酸美托洛尔缓释片治疗冠状动脉粥样硬化性心脏病并慢性心力衰竭的效果观察[J]. 首都医科大学学报, 2020, 41(1): 113-118.
[15]	郝鹏, 冯斯婷, 甄雷, 王晓, 王春梅, 聂绍平. SYNTAX II评分对急性ST段抬高型心肌梗死患者直接PCI术后无复流的预测价值[J]. 首都医科大学学报, 2019, 40(5): 744-748.

守护生命的“心”路——周玉杰教授

Guardian of the heart——Professor Zhou Yujie

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价